Efficacy News and Research

RSS

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

What is the impact of the SARS-CoV-2 omicron wave in South Africa?

A new study has described the transmissibility of SARS-CoV-2, population-level immunity, and impact of omicron wave in South Africa.

27 Aug 2022

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

A three-drug medication known as a "polypill," developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.

26 Aug 2022

Novavax COVID-19 vaccine granted UK approval for 12- to 17-year-olds by MHRA

Nuvaxovid, the COVID-19 vaccine developed by Novavax, has today been granted an extension to its existing UK approval, for 12- to 17-year-olds. This extension has been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

26 Aug 2022

Durable coating may soon be a new weapon in the fight against germs

There may soon be a new weapon in our centuries-old battle against germs: the first durable coating that can quickly kill bacteria and viruses and keep on killing them for months at a time.

26 Aug 2022

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

A new study reported a single-cell adenovirus (SC-Ad) which replicates the antigen genes substantially without producing infectious progeny.

26 Aug 2022

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

Hepatitis B virus (HBV) infection is global in nature and induces several incredible liver diseases, such as chronic hepatitis B (CHB), cirrhosis of the liver (LC) and hepatocellular carcinoma (HCC). A total of 882,000 patients died of HBV-related liver diseases in 2019.

25 Aug 2022

New study investigates a potential treatment for people diagnosed with monkeypox

The team behind the world-leading RECOVERY trial of COVID-19 treatments are leading a new study investigating a potential treatment for people who have been diagnosed with monkeypox.

25 Aug 2022

What is the efficacy of Grignard Pure™ against surrogate of SARS-CoV-2?

Researchers characterized the efficacy of Grignard Pure™ (GP) in inactivating MS2 bacteriophage, a non-enveloped viral microbe that has been used widely as a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) surrogate.

25 Aug 2022

What is the link between influenza vaccination and the severity of COVID-19 infection?

Researchers performed a systematic review and meta-analysis to investigate whether influenza vaccinations could reduce COVID-19 severity outcomes.

25 Aug 2022

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

In a new study, the long-term humoral immunity to SARS-CoV-2 was investigated.

25 Aug 2022

Experimental, genetically attenuated malaria vaccine warrants further exploration

Findings from a preliminary human study of an experimental, genetically attenuated malaria parasite immunization show this vaccine warrants further exploration.

24 Aug 2022

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

Australia's first dedicated children's immunotherapy center will investigate treatments to not only increase the survival of kids with cancer, but to also improve their ongoing quality of life.

24 Aug 2022

What are the effects of non-nutritive sweeteners on the human gut microbiome?

Researchers evaluated the short-term effects of four non-nutritive sweeteners on the human microbiome, glucose tolerance, and additional health parameters in a randomized-controlled trial encompassing 120 healthy adults.

24 Aug 2022

Absolute vaccine effectiveness for third and fourth doses of mRNA COVID-19 vaccine against Omicron

Researchers analyzed the efficacy of the SARS-CoV-2 fourth-dose vaccination relative to no vaccination towards the Omicron BA.1 variant.

24 Aug 2022

Case report on the post-orgasmic illness treated with antihistamines

Scientists discuss a post-orgasmic illness syndrome patient’s experience of being treated with an antihistamine.

23 Aug 2022

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

23 Aug 2022

Efficacy News and Research

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

What is the impact of the SARS-CoV-2 omicron wave in South Africa?

Three-drug medication effective in preventing recurrent cardiovascular events after a heart attack

Novavax COVID-19 vaccine granted UK approval for 12- to 17-year-olds by MHRA

Durable coating may soon be a new weapon in the fight against germs

New study provides comparison of replicating and non-replicating vaccines against SARS-CoV-2

Immune therapy may be an alternate therapeutic approach for treating chronic hepatitis B

New study investigates a potential treatment for people diagnosed with monkeypox

What is the efficacy of Grignard Pure™ against surrogate of SARS-CoV-2?

What is the link between influenza vaccination and the severity of COVID-19 infection?

Study investigates factors that influence immune responses over 15 months after SARS-CoV-2 infection

Experimental, genetically attenuated malaria vaccine warrants further exploration

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

What are the effects of non-nutritive sweeteners on the human gut microbiome?

Absolute vaccine effectiveness for third and fourth doses of mRNA COVID-19 vaccine against Omicron

Case report on the post-orgasmic illness treated with antihistamines

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Caffeine metabolite could become a valuable treatment for myopia in children

Epistasis leads to the reduction in genetic barrier to COVID-19 neutralizing antibody escape

Insights into the biology of the monkeypox virus

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News